Results for tag: "Human Endostatin"

Endostatin is a human endostatin-based drug used in the treatment of cancer. It is a recombinant form of the naturally occurring protein endostatin, which is found in the human body and is known to inhibit the growth of new blood vessels. Endostatin is used to treat a variety of cancers, including breast, lung, and colorectal cancer. It is also used to treat metastatic melanoma and other solid tumors. Endostatin is administered intravenously and is typically used in combination with other cancer treatments, such as chemotherapy and radiation therapy. Endostatin has been shown to be effective in slowing the growth of tumors and prolonging survival in some patients. Endostatin is a promising drug in the oncology market, as it has the potential to improve the quality of life for cancer patients. It is also being studied for its potential to treat other diseases, such as diabetes and cardiovascular disease. Some companies in the Human Endostatin market include Merck, Pfizer, Novartis, and AstraZeneca. Show Less Read more